Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 3:17 PM
Ignite Modification Date:
2025-12-24 @ 3:17 PM
NCT ID:
NCT07169292
Eligibility Criteria:
Inclusion Criteria
* Female participants.
* Aged 20 to 40 years.
* Diagnosed with Polycystic Ovary Syndrome (PCOS) according to the Rotterdam criteria.
* Willing to participate in the study and provide informed consent.
* Not using any of the following in the last month: (Hormonal medications for menstruation, Herbal menstrual remedies or Metformin).
Exclusion Criteria
* Known diagnosis of uncontrolled thyroid dysfunction.
* Diagnosis of diabetes mellitus.
* Elevated FSH levels above 20 mIU/mL.
* Hyperprolactinemia with serum levels above 1000 mIU/L.
* Pregnant or lactating women.
* Known coagulation disorders.
* Anemia with hemoglobin levels less than 10 g/dL.
* History of undergoing dry cupping, wet cupping, or acupuncture in the past 6 months.
* History of surgical removal of both ovaries or the uterus.
* Other causes of hyperandrogenism, including:
* Late-onset non-classic 21-hydroxylase deficiency (excluded clinically; lab investigation if clinically indicated).
* Ovarian androgen-secreting tumors.
* Use of anabolic or androgenic drugs.
* Cushing's syndrome.
* Hypothalamic or pituitary disorders causing amenorrhea.
* Primary ovarian insufficiency.
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
20 Years
Maximum Age:
40 Years
Study:
NCT07169292
Study Brief:
Protocol Section:
NCT07169292